Latest News and Press Releases
Want to stay updated on the latest news?
-
New clinical data show durable remissions and long-tail survivors including >2-year complete remissions in chemotherapy- and checkpoint-refractory cancersGVHD trial launching through non-dilutive...
-
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority...
-
Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Ransomware Preparedness Assessment Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. Ransomware...
-
Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Ransomware Detection & Response Software Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. ...
-
Glendale, CA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Jackbit, operated by Ryker B.V, leads as one of the fastest paying online crypto casinos and sportsbook by Betcha.world. A casino review platform...
-
El Paso, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- El Paso, Texas [November 13, 2025] – Endeavors, a national nonprofit and one of the top three veteran service providers in Texas, officially opened...
-
100% LLDAS response rate observed in patients with SLE who received Descartes-08 in Phase 2 open-label trial reaching Month 3 follow-up (n=3) Disease remission reported as DORIS response seen in 2...
-
In the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with pancreatic ductal adenocarcinoma (“PDAC”), fewer disease progressions and deaths than projected have been observed as of...
-
New York City, NY, Nov. 13, 2025 (GLOBE NEWSWIRE) -- What Is GPT Invest? In 2025, GPT Invest stands out as a next-generation trading infrastructure built on advanced algorithmic intelligence,...
-
New York City, NY, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Intro As the global wellness industry experiences a significant shift toward natural immune-support solutions, Herpafend has emerged as a...